GLP-1 receptor agonists and risk of hepatocellular carcinoma and all-cause mortality in patients with MASLD and type 2 diabetes: a propensity score-matched population-based cohort study.

GLP-1 受體促效劑對合併 MASLD 與第二型糖尿病患者肝細胞癌及全因死亡率之影響：一項傾向分數配對的全國性世代研究